This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Alon Wellner, PhD
Vice President Biology and Co-Founder at Aureka Biotechnologies


Alon is the co-founder of Aureka Biotechnologies, where he currently holds the position of Vice President of Biology. With over five years of experience as a senior postdoctoral scholar at UC Irvine, he specialized in developing advanced systems for accelerated antibody engineering. Alon's work involved integrating yeast surface display with orthogonal replication techniques. He obtained his PhD from the prestigious Weizmann Institute of Science in Israel, under the guidance of the late Dan Tawfik.

Agenda Sessions

  • Next-Gen Antibody Engineering: Yeast-Derived Hypermutation and Machine Learning for GPCR Therapeutics